Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Change in Cash (2016 - 2025)

Historic Change in Cash for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $18.0 million.

  • Dare Bioscience's Change in Cash rose 44810.73% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 53913.48%. This contributed to the annual value of $5.2 million for FY2024, which is 12174.11% up from last year.
  • Latest data reveals that Dare Bioscience reported Change in Cash of $18.0 million as of Q3 2025, which was up 44810.73% from -$5.3 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Change in Cash registered a high of $36.5 million during Q3 2021, and its lowest value of -$14.8 million during Q1 2023.
  • Its 5-year average for Change in Cash is $984515.5, with a median of -$3.4 million in 2023.
  • As far as peak fluctuations go, Dare Bioscience's Change in Cash skyrocketed by 8560128.34% in 2021, and later crashed by 101671.19% in 2024.
  • Dare Bioscience's Change in Cash (Quarter) stood at $6.1 million in 2021, then crashed by 193.72% to -$5.7 million in 2022, then soared by 40.24% to -$3.4 million in 2023, then skyrocketed by 230.63% to $4.5 million in 2024, then soared by 303.99% to $18.0 million in 2025.
  • Its last three reported values are $18.0 million in Q3 2025, -$5.3 million for Q2 2025, and -$5.4 million during Q1 2025.